Bigul

Abbott India Ltd - 500488 - Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2019

Please find enclosed Certificate dated October 15, 2019 issued by Ms. Neena Bhatia, Practicing Company Secretary, pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2019.
15-10-2019
Bigul

Abbott India Ltd - 500488 - Shareholding for the Period Ended September 30, 2019

Abbott India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
11-10-2019
Bigul

Abbott India Ltd - 500488 - Statement Of Investor Complaints For The Quarter Ended September 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0211 Name of the Signatory :- Krupa AnandparaDesignation :- Company Secretary and Compliance Officer
10-10-2019
Bigul

ABBOTT INDIA LTD. - 500488 - Compliance Certificate For The Half Year Ended September 30, 2019

Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Compliance Certificate dated October 7, 2019, duly signed by the Compliance Officer of the Company and Authorized Representative of the Registrar and Share Transfer Agent i.e., Karvy Fintech Private Limited for the half year ended September 30, 2019.
07-10-2019
Bigul

Abbott India hits all-time high, surges 35% in two months

Abbott India had reported a 42 per cent year-on-year (YoY) jump in net profit at Rs 117 crore for Q1FY20.
03-10-2019
Bigul

ABBOTT INDIA LTD. - 500488 - Closure of Trading Window

This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2019, the Trading Window for dealing in the shares of the Company by the Designated Persons and their immediate relatives shall remain closed from tomorrow i.e. Tuesday, October 1, 2019 and the same shall reopen on 48 hours after the declaration of Unaudited Financial Results for the second quarter ended on September 30, 2019.
30-09-2019
Bigul

Abbott India Ltd - 500488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 of the Listing Regulations, please find attached the details of the Tele-conference with Institutional Shareholder. Please note that the above schedule is subject to change on account of exigencies on the part of these Institutional Shareholder of the Company. The said intimation is available on the website of the Company at www.abbott.co.in
27-09-2019
Bigul

Healthy sales in branded portfolio lift Abbott India's margins in Q1

Incremental growth to be led by new launches, expansion into new therapies
27-08-2019
Bigul

Abbott India Ltd - 500488 - Proceedings Of The 75Th Annual General Meeting - Abbott India Limited

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed proceedings of the 75th Annual General Meeting of the Company held on August 22, 2019.
23-08-2019
Bigul

Abbott India Ltd - 500488 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Abbott India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
23-08-2019
Next Page
Close

Let's Open Free Demat Account